Atrial-Selective Sodium Channel Blockers: Do They Exist?
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Pharmacology
Reference46 articles.
1. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).;Fuster;J Am Coll Cardiol,2006
2. Innovative approaches to anti-arrhythmic drug therapy.;Nattel;Nat Rev Drug Discov,2006
3. Early class III drugs for the treatment of atrial fibrillation: Efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.;Blaauw;Circulation,2004
4. Azd7009: A new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.;Goldstein;J Cardiovasc Electrophysiol,2004
5. The mechanism of atrial antiarrhythmic action of RSD1235.;Fedida;J Cardiovasc Electrophysiol,2005
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigational Anti–Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?;Journal of Cardiovascular Pharmacology;2020-11
2. The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity;Journal of Cardiovascular Pharmacology;2020-05-20
3. Electrocardiological effects of ranolazine and lidocaine on normal and diabetic rat atrium;Journal of Interventional Cardiac Electrophysiology;2020-04-23
4. Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents;Frontiers in Pharmacology;2020-04-20
5. Class I Antiarrhythmic Drugs: Na+ Channel Blockers;Antiarrhythmic Drugs;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3